Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q27852894)
Watch
English
Loss of NF1 in cutaneous melanoma is associated with RAS activation and MEK dependence
scientific article
Loss of NF1 in Cutaneous Melanoma Is Associated with RAS Activation and MEK Dependence
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
PubMed
PubMed ID
24576830
retrieved
13 November 2016
title
Loss of NF1 in cutaneous melanoma is associated with RAS activation and MEK dependence
(English)
1 reference
stated in
PubMed
PubMed ID
24576830
retrieved
13 November 2016
main subject
cell line
0 references
author
Antoni Ribas
series ordinal
12
0 references
Nikolaus Schultz
object named as
Nikolaus Schultz
series ordinal
16
0 references
Christine A Pratilas
series ordinal
2
object named as
Christine A Pratilas
0 references
Zhan Yao
object named as
Zhan Yao
series ordinal
10
1 reference
stated in
ORCID Public Data File 2021
author name string
Moriah H Nissan
series ordinal
1
0 references
Alexis M Jones
series ordinal
3
0 references
Ricardo Ramirez
series ordinal
4
0 references
Helen Won
series ordinal
5
0 references
Cailian Liu
series ordinal
6
0 references
Shakuntala Tiwari
series ordinal
7
0 references
Li Kong
series ordinal
8
0 references
Aphrothiti J Hanrahan
series ordinal
9
0 references
Taha Merghoub
series ordinal
11
0 references
Paul B Chapman
series ordinal
13
0 references
Rona Yaeger
series ordinal
14
0 references
Barry S Taylor
series ordinal
15
0 references
Michael F Berger
series ordinal
17
0 references
Neal Rosen
series ordinal
18
0 references
David B Solit
series ordinal
19
0 references
language of work or name
English
0 references
publication date
15 April 2014
0 references
published in
Cancer Research
0 references
volume
74
0 references
page(s)
2340-50
0 references
issue
8
0 references
describes a project that uses
A2058
0 references
Malme-3M
0 references
SK-MEL-1
0 references
SK-MEL-100
0 references
SK-MEL-103
0 references
SK-MEL-105
0 references
SK-MEL-109
0 references
SK-MEL-11
0 references
SK-MEL-110
0 references
SK-MEL-113
0 references
SK-MEL-117
0 references
SK-MEL-118
0 references
SK-MEL-119
0 references
SK-MEL-12
0 references
SK-MEL-127
0 references
SK-MEL-13
0 references
SK-MEL-130
0 references
SK-MEL-131
0 references
SK-MEL-133
0 references
SK-MEL-146
0 references
SK-MEL-147
0 references
SK-MEL-15
0 references
SK-MEL-153
0 references
SK-MEL-161
0 references
SK-MEL-170
0 references
SK-MEL-173
0 references
SK-MEL-174
0 references
SK-MEL-176
0 references
SK-MEL-178
0 references
SK-MEL-181
0 references
SK-MEL-182
0 references
SK-MEL-186
0 references
SK-MEL-187
0 references
SK-MEL-188
0 references
SK-MEL-19
0 references
SK-MEL-190
0 references
SK-MEL-191
0 references
SK-MEL-192
0 references
SK-MEL-196
0 references
SK-MEL-197
0 references
SK-MEL-199
0 references
SK-MEL-2
0 references
SK-MEL-200
0 references
SK-MEL-202
0 references
SK-MEL-205
0 references
SK-MEL-207
0 references
SK-MEL-208
0 references
SK-MEL-209
0 references
SK-MEL-21
0 references
SK-MEL-210-3
0 references
SK-MEL-215-1
0 references
SK-MEL-217
0 references
SK-MEL-22
0 references
SK-MEL-222
0 references
SK-MEL-227
0 references
SK-MEL-228
0 references
SK-MEL-229
0 references
SK-MEL-23
0 references
SK-MEL-230
0 references
SK-MEL-232
0 references
SK-MEL-233
0 references
SK-MEL-234
0 references
SK-MEL-237
0 references
SK-MEL-238
0 references
SK-MEL-239
0 references
SK-MEL-24
0 references
SK-MEL-243
0 references
SK-MEL-244
0 references
SK-MEL-246
0 references
SK-MEL-252
0 references
SK-MEL-256
0 references
SK-MEL-26
0 references
SK-MEL-264
0 references
SK-MEL-265
0 references
SK-MEL-266
0 references
SK-MEL-267
0 references
SK-MEL-268
0 references
SK-MEL-269
0 references
SK-MEL-27
0 references
SK-MEL-271
0 references
SK-MEL-272
0 references
SK-MEL-275
0 references
SK-MEL-276
0 references
SK-MEL-279
0 references
SK-MEL-28
0 references
SK-MEL-282
0 references
SK-MEL-283
0 references
SK-MEL-284
0 references
SK-MEL-285
0 references
SK-MEL-29
0 references
SK-MEL-30
0 references
SK-MEL-301
0 references
SK-MEL-304
0 references
SK-MEL-306
0 references
SK-MEL-307
0 references
SK-MEL-309B
0 references
SK-MEL-31
0 references
SK-MEL-313
0 references
SK-MEL-315-02
0 references
SK-MEL-315-05
0 references
SK-MEL-316
0 references
SK-MEL-318
0 references
SK-MEL-32
0 references
SK-MEL-321A
0 references
SK-MEL-321B
0 references
SK-MEL-323
0 references
SK-MEL-325
0 references
SK-MEL-326
0 references
SK-MEL-330
0 references
SK-MEL-332
0 references
SK-MEL-334
0 references
SK-MEL-339
0 references
SK-MEL-346
0 references
SK-MEL-35
0 references
SK-MEL-351
0 references
SK-MEL-359
0 references
SK-MEL-36
0 references
SK-MEL-364
0 references
SK-MEL-366
0 references
SK-MEL-367
0 references
SK-MEL-369
0 references
SK-MEL-37
0 references
SK-MEL-380
0 references
SK-MEL-381
0 references
SK-MEL-39
0 references
SK-MEL-390
0 references
SK-MEL-391
0 references
SK-MEL-393
0 references
SK-MEL-394
0 references
SK-MEL-398
0 references
SK-MEL-40
0 references
SK-MEL-400
0 references
SK-MEL-406
0 references
SK-MEL-408
0 references
SK-MEL-41
0 references
SK-MEL-410
0 references
SK-MEL-411
0 references
SK-MEL-412Parotid
0 references
SK-MEL-413-2
0 references
SK-MEL-423A
0 references
SK-MEL-423B
0 references
SK-MEL-426
0 references
SK-MEL-427
0 references
SK-MEL-428
0 references
SK-MEL-430
0 references
SK-MEL-431
0 references
SK-MEL-432
0 references
SK-MEL-435
0 references
SK-MEL-439
0 references
SK-MEL-441
0 references
SK-MEL-444
0 references
SK-MEL-445
0 references
SK-MEL-446
0 references
SK-MEL-447
0 references
SK-MEL-451
0 references
SK-MEL-452
0 references
SK-MEL-455
0 references
SK-MEL-457
0 references
SK-MEL-459
0 references
SK-MEL-462
0 references
SK-MEL-464A
0 references
SK-MEL-464B
0 references
SK-MEL-479
0 references
SK-MEL-481
0 references
SK-MEL-483
0 references
SK-MEL-495
0 references
SK-MEL-498
0 references
SK-MEL-5
0 references
SK-MEL-506
0 references
SK-MEL-507
0 references
SK-MEL-509
0 references
SK-MEL-513
0 references
SK-MEL-524
0 references
SK-MEL-529
0 references
SK-MEL-534
0 references
SK-MEL-538
0 references
SK-MEL-64
0 references
SK-MEL-7
0 references
SK-MEL-73
0 references
SK-MEL-75
0 references
SK-MEL-85
0 references
SK-MEL-90
0 references
WM1382
0 references
WM3211
0 references
WM3918
0 references
WM793
0 references
WM88
0 references
cites work
Mechanism of MEK inhibition determines efficacy in mutant KRAS- versus BRAF-driven cancers
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4005042
retrieved
20 March 2017
TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4005042
retrieved
20 March 2017
MEK162 for patients with advanced melanoma harbouring NRAS or Val600 BRAF mutations: a non-randomised, open-label phase 2 study
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4005042
retrieved
20 March 2017
A genome-scale RNA interference screen implicates NF1 loss in resistance to RAF inhibition
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4005042
retrieved
20 March 2017
Elucidating distinct roles for NF1 in melanomagenesis
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4005042
retrieved
20 March 2017
Relief of profound feedback inhibition of mitogenic signaling by RAF inhibitors attenuates their activity in BRAFV600E melanomas
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4005042
retrieved
20 March 2017
Comprehensive molecular portraits of human breast tumours
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4005042
retrieved
20 March 2017
Genome sequencing identifies a basis for everolimus sensitivity
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4005042
retrieved
20 March 2017
A landscape of driver mutations in melanoma
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4005042
retrieved
20 March 2017
Improved survival with vemurafenib in melanoma with BRAF V600E mutation
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4005042
retrieved
20 March 2017
BRAF gene amplification can promote acquired resistance to MEK inhibitors in cancer cells harboring the BRAF V600E mutation
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4005042
retrieved
20 March 2017
Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4005042
retrieved
20 March 2017
Ensembl's 10th year
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4005042
retrieved
20 March 2017
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4005042
retrieved
20 March 2017
The RIN: an RNA integrity number for assigning integrity values to RNA measurements
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4005042
retrieved
20 March 2017
Inactivation of the NF1 gene in human melanoma and neuroblastoma cell lines without impaired regulation of GTP.Ras
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4005042
retrieved
20 March 2017
Mutations of the BRAF gene in human cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4005042
retrieved
20 March 2017
Targeting RAS signalling pathways in cancer therapy
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4005042
retrieved
20 March 2017
Active Ras induces heterodimerization of cRaf and BRaf
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4005042
retrieved
20 March 2017
Lineage dependency and lineage-survival oncogenes in human cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4005042
retrieved
20 March 2017
Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4005042
retrieved
20 March 2017
Integrative genomics viewer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4005042
retrieved
7 April 2017
BRAF mutation predicts sensitivity to MEK inhibition
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4005042
retrieved
7 April 2017
Phase II trial of MEK inhibitor selumetinib (AZD6244, ARRY-142886) in patients with BRAFV600E/K-mutated melanoma.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4005042
retrieved
29 September 2017
High-throughput detection of actionable genomic alterations in clinical tumor samples by targeted, massively parallel sequencing
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4005042
retrieved
29 September 2017
Genomic complexity and AKT dependence in serous ovarian cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4005042
retrieved
29 September 2017
Concurrent loss of the PTEN and RB1 tumor suppressors attenuates RAF dependence in melanomas harboring (V600E)BRAF
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4005042
retrieved
29 September 2017
Resistance to MEK inhibitors: should we co-target upstream?
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4005042
retrieved
29 September 2017
GSK1120212 (JTP-74057) is an inhibitor of MEK activity and activation with favorable pharmacokinetic properties for sustained in vivo pathway inhibition
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4005042
retrieved
29 September 2017
4E-BP1 is a key effector of the oncogenic activation of the AKT and ERK signaling pathways that integrates their function in tumors
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4005042
retrieved
29 September 2017
Genomic and biological characterization of exon 4 KRAS mutations in human cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4005042
retrieved
29 September 2017
Proteasomal and genetic inactivation of the NF1 tumor suppressor in gliomagenesis
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4005042
retrieved
29 September 2017
Mechanisms in the pathogenesis of malignant tumours in neurofibromatosis type 1.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4005042
retrieved
29 September 2017
(V600E)BRAF is associated with disabled feedback inhibition of RAF-MEK signaling and elevated transcriptional output of the pathway
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4005042
retrieved
29 September 2017
TORC1 is essential for NF1-associated malignancies
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4005042
retrieved
29 September 2017
The NF1 tumor suppressor critically regulates TSC2 and mTOR.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4005042
retrieved
29 September 2017
Management of cutaneous melanoma
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4005042
retrieved
29 September 2017
Control of ras activation
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4005042
retrieved
29 September 2017
Neurofibromatosis-1 gene deletions and mutations in de novo adult acute myeloid leukemia
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4005042
retrieved
27 November 2018
Clinical responses to selumetinib (AZD6244; ARRY-142886)-based combination therapy stratified by gene mutations in patients with metastatic melanoma
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4005042
retrieved
27 November 2018
Analysis of BRAF and N-RAS mutations in metastatic melanoma tissues.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4005042
retrieved
27 November 2018
Mitogen-actived protein kinase activation is an early event in melanoma progression.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4005042
retrieved
27 November 2018
Flow cytometric analysis of G1- and G2/M-phase subpopulations in mammalian cell nuclei using side scatter and DNA content measurements
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4005042
retrieved
27 November 2018
Deletion of the tumor-suppressor gene NF1 occurs in 5% of myeloid malignancies and is accompanied by a mutation in the remaining allele in half of the cases
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/24576830
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
BRAF and RAS mutations in human lung cancer and melanoma
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/24576830
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Mutations in the neurofibromatosis 1 gene in sporadic malignant melanoma cell lines
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/24576830
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Somatic deletion of the neurofibromatosis type 1 gene in a neurofibrosarcoma supports a tumour suppressor gene hypothesis
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/24576830
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Identifiers
DOI
10.1158/0008-5472.CAN-13-2625
1 reference
stated in
Consolidated OpenCitations Corpus – April 2017
OpenCitations bibliographic resource ID
2427696
OpenCitations bibliographic resource ID
2427696
1 reference
stated in
Consolidated OpenCitations Corpus – April 2017
OpenCitations bibliographic resource ID
2427696
PMCID
4005042
1 reference
stated in
Consolidated OpenCitations Corpus – April 2017
OpenCitations bibliographic resource ID
2427696
PubMed ID
24576830
1 reference
stated in
Consolidated OpenCitations Corpus – April 2017
OpenCitations bibliographic resource ID
2427696
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
